Old Drug Turned ‘Cash Cow’ as Company Pumped Price to $40K a Vial, Emails Show | Kaiser Health News
▻https://khn.org/news/mallinckrodt-orphan-drug-acthar-turned-cash-cow-as-drugmaker-raised-price-to-40
Et couvert par l’Etat (qui, un jour, va arguer des dépenses excessives pour augmenter la part à payer par le patient)
Revenue from Medicare rose from under $50 million in 2011 to $725 million in 2018.